Issue of Equity

8 Nov 2006 16:35

Cyprotex PLC08 November 2006 Press Release 8 November 2006 Cyprotex PLC ("Cyprotex" or "the Company") Cyprotex PLC (AIM:CRX), the drug discovery technology and information company,today announces that under The Cyprotex PLC Unapproved Discretionary ShareOption Scheme it has issued 25,032 new ordinary shares of 0.1p each ("newOrdinary Shares") pursuant to the exercise of options. The issue of these new Ordinary shares is subject to admission to trading onAIM, application for which has been made. Trading in the new Ordinary Shares,which will rank pari passu in all respects with the existing ordinary shares. - Ends - For further information:Cyprotex PLCRobert Morrisson Atwater Tel: +44 (0) 1625 505100Chairman & Chief Executive Officeriir@cyprotex.com www.cyprotex.com Media enquiries:Abchurch CommunicationsHeather Salmond Tel + 44 (0) 20 7398 7700heather.salmond@abchurch-group.com www.abchurch-group.com This information is provided by RNS The company news service from the London Stock Exchange